Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
This would result in the optimization of both, patient-related and procedural, outcomes
Purity might be 99.2% in one batch and 98.7% in the next
Published Phase 2 data provides a timeline for GI adverse event duration: Phase Timeline Stomach Pain Severity Initial dose Weeks 1-2 Onset of GI symptoms mild to moderate cramping and nausea Dose escalation Weeks 2-8 Peak GI discomfort each dose increase can trigger a new wave of symptoms Stabilization Weeks 8-16 Symptoms begin to diminish as the body adapts to stable dosing Maintenance Weeks 16+ Most participants report significant GI symptom improvement or resolution The Phase 2 trial (48 weeks) confirmed that the majority of GI adverse events including stomach pain were concentrated in the dose-escalation period and attenuated over time
As a result, iron becomes trapped in storage sites and less available for red blood cell production
Medication makes it easier to adopt healthy habits, while healthy habits improve health outcomes
